Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Bleda

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factorSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
International Journal of Cardiology|July 4, 2016
Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cellsSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
International Journal of Vascular Medicine|April 27, 2012
Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patientsSilvia Bleda, Joaquín de Haro, Francisco Acin, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 2, 2020
Effect of clopidogrel vs. aspirin on pro-atherosclerotic NLRP1 inflammasome expression in endothelial cells. ECLOAS studySilvia Bleda, Joaquin de Haro, Isabel Sánchez, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 11, 2012
Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trialsFrancisco Acin, Joaquin de Haro, Silvia Bleda, et al.
BMC Cardiovascular Disorders|February 16, 2012
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentanJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Journal of Vascular Surgery|March 28, 2015
Aspirin therapy inhibits NLRP1 (nucleotide-binding domain-like receptor protein 1) inflammasome gene expression in patients with peripheral artery diseaseSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
The American Journal of Cardiology|December 15, 2015
Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial DiseaseJoaquin De Haro, Silvia Bleda, Cesar Varela, et al.
The American Journal of Cardiology|May 23, 2017
Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial)Joaquin De Haro, Ignacio Michel, Silvia Bleda, et al.
Journal of Vascular Surgery|March 30, 2010
A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudicationJoaquin de Haro, Francisco Acin, Aurora Florez, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|March 27, 2015
C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factorSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
International Journal of Cardiology|July 4, 2016
Elevated levels of triglycerides and vldl-cholesterol provoke activation of nlrp1 inflammasome in endothelial cellsSilvia Bleda, Joaquin de Haro, Cesar Varela, et al.
International Journal of Vascular Medicine|April 27, 2012
Enhanced vascular endothelial growth factor gene expression in ischaemic skin of critical limb ischaemia patientsSilvia Bleda, Joaquín de Haro, Francisco Acin, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|August 2, 2020
Effect of clopidogrel vs. aspirin on pro-atherosclerotic NLRP1 inflammasome expression in endothelial cells. ECLOAS studySilvia Bleda, Joaquin de Haro, Isabel Sánchez, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|October 11, 2012
Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trialsFrancisco Acin, Joaquin de Haro, Silvia Bleda, et al.
BMC Cardiovascular Disorders|February 16, 2012
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentanJoaquin De Haro, Francisco Acin, Silvia Bleda, et al.
Journal of Vascular Surgery|March 28, 2015
Aspirin therapy inhibits NLRP1 (nucleotide-binding domain-like receptor protein 1) inflammasome gene expression in patients with peripheral artery diseaseSilvia Bleda, Joaquin De Haro, Cesar Varela, et al.
The American Journal of Cardiology|December 15, 2015
Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial DiseaseJoaquin De Haro, Silvia Bleda, Cesar Varela, et al.
The American Journal of Cardiology|May 23, 2017
Carotid Stenting in Patients With High Risk Versus Standard Risk for Open Carotid Endarterectomy (REAL-1 Trial)Joaquin De Haro, Ignacio Michel, Silvia Bleda, et al.
Journal of Vascular Surgery|March 30, 2010
A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudicationJoaquin de Haro, Francisco Acin, Aurora Florez, et al.
Pageof 5